Shaked, Y., Emmenegger, U., Man, S., Cervi, D., Bertolini, F., Ben-David, Y., & Kerbel, R. S. (2005). Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity. The American Society of Hematology.

Shaked, Yuval, Urban Emmenegger, Shan Man, Dave Cervi, Francesco Bertolini, Yaacov Ben-David, und Robert S. Kerbel. Optimal Biologic Dose of Metronomic Chemotherapy Regimens Is Associated With Maximum Antiangiogenic Activity. The American Society of Hematology, 2005.

Shaked, Yuval, et al. Optimal Biologic Dose of Metronomic Chemotherapy Regimens Is Associated With Maximum Antiangiogenic Activity. The American Society of Hematology, 2005.